AmeriPath Reports on 2003, Its First Year as a Private Firm

WILL BUSINESS BE BETTER for AmeriPath, Inc. as a private company than it was as a publicly-traded firm? Its 2003 financial report indicates some interesting challenges, many common to all laboratories. First, a look at basic numbers. AmeriPath’s net revenues grew from $478.8 million in 2002 to $485.0 million in 2003. That’s a growth rate …

AmeriPath Reports on 2003, Its First Year as a Private Firm Read More »

To access this post, you must purchase The Dark Report.

AmeriPath Reports on 2003, Its First Year as a Private Firm

Company reports that Quest is internalizing anatomic pathology contracts at a steady rate

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month